Engaging General Practice in the Prevention of Patients With Alcohol Problems
21 september 2009 uppdaterad av: Radboud University Medical Center
The aim of the study is to test whether or not a tailored multi-component intervention program to increase the activity of general practice teams in the prevention of hazardous and harmful alcohol consumption results in increase advice giving rate to patient with hazardous and harmful alcohol consumption and a better patient outcome in terms of hazardous and harmful alcohol consumption.
The primary objectives of the proposed study are:
- to test the (cost) effectiveness of a tailored multi-component implementation program to engage general practices (i.e. GPs, nurse practitioners or practice nurses/assistants) in the prevention of hazardous or harmful alcohol consumption, changing both providers' advice giving behaviour and patients' alcohol consumption
- to identify predictors of effect
- to examine whether or not the implementation of a tailored multi-component implementation program to engage general practice in the prevention of hazardous or harmful alcohol consumption is feasible.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
- Beteende: Feedback about patients at risk
- Beteende: Dissemination guideline and patient information letters
- Beteende: Tailored educational training
- Beteende: Tailored outreach based facilitator support
- Beteende: Facilitation of co-operation with local addiction services
- Beteende: Patient directed interventions
- Beteende: Reminder-card for GP's desk
- Beteende: Personal feedback to patients
Detaljerad beskrivning
Hazardous and harmful alcohol consumption is likely to cause damage to health, either physical or mental. The prevention of harmful alcohol consumption results in a reduction of alcohol related diseases, of emergency and hospital use, and of societal related problems, and it results in direct health care savings as well as in non-health care savings. General practice is an important setting to intervene with patients whose drinking is hazardous or harmful to their health. Despite the evidence for the efficacy and cost effectiveness of case finding and brief interventions in general practice, such interventions are rarely integrated into routine practice. Based on the literature it is recommended to develop a tailored multi-component implementation program to engage general practice in the prevention of patients with alcohol consumption.
In our trial such a tailored multi-component intervention program is offered to the general practice team (GPT). The participants in our trial are the GPT, not the patients. The GPTs practising in Mid-West and Mid-South are invited to participate in the trial by an invitational letter, including an information leaflet. Participation is not obligatory, but based on own interest of the GPT. Next, GPTs who are willing to participate in the trial are random allocated to the intervention or control condition. Besides the effect outcome measures described in the 'Outcome measure" part there are process and costs measures described.
Besides measurements at the GPT-level, we also conduct measurements at the patient level. All patients of 18 years or older visiting the GPT during a pre-defined 3-month period are asked to fill in the Alcohol Use Disorders identification Test (AUDIT). This measurement takes place before the intervention starts. Only those patients at risk are asked to fill in the AUDIT after the intervention ended. As described in the 'Outcome part', the AUDIT is used to describe the effects of the intervention program at the patient level. Patients receive individual feedback with personal advice depending on their AUDIT score. Patients are not informed about whether the GPT is allocated to the intervention program or control condition (usual care) (single blind).
Comparison: GPTs participated in the multi-component intervention program (see Interventions; intervention group) are compared to GPTs who didn't participate in the multi-component intervention program (control group). The GPTs in the control group receive the NHG guideline and NHG patient information letters, which can be seen as usual care. In addition the receive feedback about the number of patients at risk because of their alcohol consumption, which can be seen as a minimal intervention.
Studietyp
Interventionell
Inskrivning (Faktisk)
77
Fas
- Inte tillämpbar
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Barn
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- GP
- all GPs in a GPT have to participate or
- patients should be listed per GP
There are no exclusion criteria.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Tilldelning: Randomiserad
- Interventionsmodell: Faktoriell uppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Inget ingripande: kontrollera
|
GPTs receive this feedback about their patient population; obtained through premeasurement results
Patients receive advise based on their premeasurement answers
|
|
Aktiv komparator: training
tailored multi-component implementation program
|
GPTs receive this feedback about their patient population; obtained through premeasurement results
for GP(T)s
in the practices of the GPTs
Like poster for the waiting room, self-help booklets, folders
Patients receive advise based on their premeasurement answers
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
|---|
|
- Proportion of patients who, with an initial AUDIT score of 16 or more, have an AUDIT score at follow-up (= 18 months) of 15 or less.
|
|
- Proportion of patients who, with an initial AUDIT score of 16 or more, have been given advice by the general practitioner or by other staff (e.g. nurse practitioner, practice nurse).
|
Sekundära resultatmått
Resultatmått |
|---|
|
- Average AUDIT score at follow-up (= 18 months).
|
|
- Average alcohol consumption as measured by the AUDIT at follow-up (= 18 months).
|
|
- Proportion of patients with hazardous or harmful alcohol consumption as measured by the AUDIT at follow-up (= 18 months).
|
|
- Proportion of patients with harms from alcohol as measured by the AUDIT at follow-up (= 18 months).
|
|
- Proportion of patients with alcohol dependence as measured by the AUDIT at follow-up (= 18 months).
|
|
- Average SAAPPQ score.
|
|
- Change in SAAPPQ score.
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Samarbetspartners
Utredare
- Huvudutredare: M. Laurant, PhD, Centre for Quality for Care Research Nijmegen
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Allmänna publikationer
- Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ. 1998 Aug 15;317(7156):465-8. doi: 10.1136/bmj.317.7156.465. No abstract available.
- Guilbert JJ. The world health report 2002 - reducing risks, promoting healthy life. Educ Health (Abingdon). 2003 Jul;16(2):230. doi: 10.1080/1357628031000116808. No abstract available.
- Spandorfer JM, Israel Y, Turner BJ. Primary care physicians' views on screening and management of alcohol abuse: inconsistencies with national guidelines. J Fam Pract. 1999 Nov;48(11):899-902.
- Lemmens PH. Relationship of alcohol consumption and alcohol problems at the population level. In Heather N, Peters TJ, Stockwell T (eds). International handbook of alcohol dependence and problems. Chischester: John Wiley & Sons, Ltd. 2001
- Anderson P, Cremona A, Paton A, Turner C, Wallace P. The risk of alcohol. Addiction. 1993 Nov;88(11):1493-508. doi: 10.1111/j.1360-0443.1993.tb03135.x.
- Anderson P. Alcohol and risk of physical harm. In Holder HD & Edwards G (eds). Alcohol and public policy: evidence and issues. Oxford: Oxford Medical Publications. 1995
- Garretsen HFL, Knibbe RA. Alcohol prevalentie onderzoek Rotterdam/Limburg. Landelijk eindrapport. Rijswijk: Ministerie van WVC. 1983
- Volksgezondheid Toekomst Verkenning. Natioaal Kompas Volksgezondheid. Bilthoven: RIVM, http://www.nationaal kompas.nl, versie 2.4, september 2003
- Cornel M et al. NHG Standaard M10. Problematisch alcoholgebruik. Huisarts en Wetenschap 1998; 41 (12): 582-90
- Ministerie van VWS. Zorgnota 2003
- Anderson P. The effectiveness of general practitioners' advice in reducing the risk of alcohol. IN: Neil A et al (eds). Prevention of Cardiovascular Disease: An evidence-based approach. 2nd Ed. Oxford: Oxford University Press. In press
- Sutherland G. Smoking cessation: Evidence for counseling efficacy. J of Clinical Psychiatry. In press
- Fleming MF, Mundt MP, French MT, Manwell LB, Stauffacher EA, Barry KL. Benefit-cost analysis of brief physician advice with problem drinkers in primary care settings. Med Care. 2000 Jan;38(1):7-18. doi: 10.1097/00005650-200001000-00003.
- Anderson P, Laurant M, Kaner E, Wensing M, Grol R. Engaging general practitioners in the management of hazardous and harmful alcohol consumption: results of a meta-analysis. J Stud Alcohol. 2004 Mar;65(2):191-9. doi: 10.15288/jsa.2004.65.191.
- Murphy HB. Hidden barriers to the diagnosis and treatment of alcoholism and other alcohol misuse. J Stud Alcohol. 1980 May;41(5):417-28. doi: 10.15288/jsa.1980.41.417.
- Skinner HA, Holt S. Early intervention for alcohol problems. J R Coll Gen Pract. 1983 Dec;33(257):787-91.
- Hulscher ME, Wensing M, Grol RP, van der Weijden T, van Weel C. Interventions to improve the delivery of preventive services in primary care. Am J Public Health. 1999 May;89(5):737-46. doi: 10.2105/ajph.89.5.737.
- Eccles M, Grimshaw J, Campbell M, Ramsay C. Research designs for studies evaluating the effectiveness of change and improvement strategies. Qual Saf Health Care. 2003 Feb;12(1):47-52. doi: 10.1136/qhc.12.1.47.
- Moyer A, Finney JW, Swearingen CE, Vergun P. Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction. 2002 Mar;97(3):279-92. doi: 10.1046/j.1360-0443.2002.00018.x.
- Babor TF, et al. The Alcohol Use Disorders Identification Test Guidelines for Use in Primary Care. Geneva: World Health Organization WHO/MSD/MSB/01.6a.
- Anderson P, Kaner E, Wutzke S, Wensing M, Grol R, Heather N, Saunders J; World Health Organization Brief Intervention Study Group. Attitudes and management of alcohol problems in general practice: descriptive analysis based on findings of a World Health Organization international collaborative survey. Alcohol Alcohol. 2003 Nov-Dec;38(6):597-601. doi: 10.1093/alcalc/agg119.
- Anderson P, Clement S. The AAPPQ revisited: the measurement of general practitioners' attitudes to alcohol problems. Br J Addict. 1987 Jul;82(7):753-9. doi: 10.1111/j.1360-0443.1987.tb01542.x. No abstract available.
- Fiellin DA, Reid MC, O'Connor PG. Screening for alcohol problems in primary care: a systematic review. Arch Intern Med. 2000 Jul 10;160(13):1977-89. doi: 10.1001/archinte.160.13.1977.
- Bohn MJ, Babor TF, Kranzler HR. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol. 1995 Jul;56(4):423-32. doi: 10.15288/jsa.1995.56.423.
- Babor TF, Grant M, Acuda W, Burns FH, Campillo C, Del Boca FK, Hodgson R, Ivanets NN, Lukomskya M, Machona M, et al. A randomized clinical trial of brief interventions in primary care: summary of a WHO project. Addiction. 1994 Jun;89(6):657-60; discussion 660-78. doi: 10.1111/j.1360-0443.1994.tb00944.x. No abstract available.
- Kaner E, Lock C, Heather N, McNamee P, Bond S. Promoting brief alcohol intervention by nurses in primary care: a cluster randomised controlled trial. Patient Educ Couns. 2003 Nov;51(3):277-84. doi: 10.1016/s0738-3991(02)00242-2.
- Gross PA, Greenfield S, Cretin S, Ferguson J, Grimshaw J, Grol R, Klazinga N, Lorenz W, Meyer GS, Riccobono C, Schoenbaum SC, Schyve P, Shaw C. Optimal methods for guideline implementation: conclusions from Leeds Castle meeting. Med Care. 2001 Aug;39(8 Suppl 2):II85-92.
- Grol R, Jones R. Twenty years of implementation research. Fam Pract. 2000 Feb;17 Suppl 1:S32-5. doi: 10.1093/fampra/17.suppl_1.s32. No abstract available.
- Grol R. Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med Care. 2001 Aug;39(8 Suppl 2):II46-54. doi: 10.1097/00005650-200108002-00003.
- van Bokhoven MA, Kok G, van der Weijden T. Designing a quality improvement intervention: a systematic approach. Qual Saf Health Care. 2003 Jun;12(3):215-20. doi: 10.1136/qhc.12.3.215.
- Prochaska JO, Di Clemente CC. The transtheoretical approach: crossing traditional boundaries of therapy. Homewood, IL: Dow Jones-Irwin. 1984
- Rogers EM. Diffusion of innovations. 4th ed. New York: Free Press. 1995
- Fishbein M, Ajzen I. Belief, attitude, intentention and behavior: an introduction to therory and research. Reading, MA: Addison Wesley, 1975
- Mc Guire WJ. Attitudes an attitude change. In: Lindzey G, Aronson E (eds). The handbook of social psychology. New York: Random House, 1985; 233-346
- Anderson P, Jane-Llopis E. How can we increase the involvement of primary health care in the treatment of tobacco dependence? A meta-analysis. Addiction. 2004 Mar;99(3):299-312. doi: 10.1111/j.1360-0443.2003.00672.x.
- Davis D, O'Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA. 1999 Sep 1;282(9):867-74. doi: 10.1001/jama.282.9.867.
- Hulscher ME, van Drenth BB, van der Wouden JC, Mokkink HG, van Weel C, Grol RP. Changing preventive practice: a controlled trial on the effects of outreach visits to organise prevention of cardiovascular disease. Qual Health Care. 1997 Mar;6(1):19-24. doi: 10.1136/qshc.6.1.19.
- Lobo CM, Frijling BD, Hulscher ME, Bernsen RM, Braspenning JC, Grol RP, Prins A, van der Wouden JC. Improving quality of organizing cardiovascular preventive care in general practice by outreach visitors: a randomized controlled trial. Prev Med. 2002 Nov;35(5):422-9. doi: 10.1006/pmed.2002.1095.
- Fullard E, Fowler G, Gray M. Promoting prevention in primary care: controlled trial of low technology, low cost approach. Br Med J (Clin Res Ed). 1987 Apr 25;294(6579):1080-2. doi: 10.1136/bmj.294.6579.1080.
- Astrop P. Facilitator--the birth of a new profession. Health Visit. 1988 Oct;61(10):311-2. No abstract available.
- Hulscher MEJL. Implementing prevention in general practice: a study on cardiovascular disease. Doctoral thesis. Nijmegen: 1998
- Huiberts A, Boon B. Alcoholadvies op maat online. G: vakblad over gezondheid en maatschappij 2003; 1: 28-9
- Riper H, Kramer, J Effectiviteit van een zelfhulpboekje voor probleemdrinkers. Utrecht: Trimbos-instituut. In preparation
- Hermens R. Cervical cancer screening. Quality improvement interventions in general practice. Doctoral thesis. Nijmegen: 2003
- Whitfield JB. Diagnostic and monitoring investigations. In: Heather N, et al (eds.) International handbook of alcohol dependence and problems. Chichester: John Wiley & Sons, Ltd., (2001).
- Keurhorst M, van Beurden I, Anderson P, Heinen M, Akkermans R, Wensing M, Laurant M. GPs' role security and therapeutic commitment in managing alcohol problems: a randomised controlled trial of a tailored improvement programme. BMC Fam Pract. 2014 Apr 17;15:70. doi: 10.1186/1471-2296-15-70.
- van Beurden I, Anderson P, Akkermans RP, Grol RP, Wensing M, Laurant MG. Involvement of general practitioners in managing alcohol problems: a randomized controlled trial of a tailored improvement programme. Addiction. 2012 Sep;107(9):1601-11. doi: 10.1111/j.1360-0443.2012.03868.x. Epub 2012 May 8.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 juli 2005
Primärt slutförande (Faktisk)
1 maj 2008
Avslutad studie (Faktisk)
1 april 2009
Studieregistreringsdatum
Först inskickad
21 februari 2006
Först inskickad som uppfyllde QC-kriterierna
21 februari 2006
Första postat (Uppskatta)
1 mars 2006
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
22 september 2009
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
21 september 2009
Senast verifierad
1 augusti 2009
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- KWAZO/GPA-01
- 50-50115-98-041
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Feedback about patients at risk
-
Oslo University HospitalSensocure ASHar inte rekryterat ännuIschemi lem | Kompartmentsyndrom i ben | Koldioxid | Blodcirkulationsstörning | Biosensing teknikerNorge
-
Memorial Sloan Kettering Cancer CenterRekryteringBRCA1-mutation | BRCA2-mutation | APC-genmutation | MLH1-genmutation | RAD51C genmutation | RAD51D genmutation | BRIP1 genmutation | PALB2 genmutation | PTEN-genmutation | ATM-genmutation | CHEK2 genmutation | BARD1 genmutation | MSH2 genmutation | MSH6 genmutation | PMS2 genmutation | POLD1 genmutation | CDKN2A-mutation | POLE... och andra villkorFörenta staterna
-
University Hospital, GenevaUniversity Medical Center Groningen; The Ottawa HospitalOkändDjup ventrombos | D-dimerKanada, Schweiz, Frankrike
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)IndragenPlasmacellmyelomFörenta staterna